We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

By LabMedica International staff writers
Posted on 22 Sep 2025

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. More...

Standard care can be hindered by delays in identifying the type of transfusion needed to stop bleeding. Now, a real-time blood-monitoring approach has shown potential to provide rapid, detailed insights into clotting, bringing hospitals closer to faster and more effective emergency care.

Researchers from the Keck School of Medicine of USC (Los Angeles, CA, USA) conducted a comprehensive review of viscoelastic testing (VET), a minimally invasive diagnostic technology. VET detects how well blood is clotting and identifies which blood components—such as plasma, platelets or whole blood—are most effective for treating hemorrhage. Already approved by the U.S. FDA for use in surgeries and trauma, the test is not yet standard in maternity care.

The review analyzed findings from 156 studies and included interviews with patients, providers and policymakers. Evidence suggests VET can improve management of postpartum hemorrhage, but only two randomized controlled trials were identified, highlighting the need for stronger data. The review, published in the International Journal of Obstetric Anesthesia, underscores that large-scale U.S.-based research is essential to confirm its clinical impact in maternity settings.

Adopting VET could reduce maternal deaths and improve precision in transfusion practices, preventing unnecessary use of costly whole blood products. Its potential extends beyond survival benefits, with implications for reducing health disparities, as Black women and women in rural areas face higher maternal mortality rates. Researchers recommend multicenter randomized trials and standardized protocols to guide adoption, ensuring VET is implemented effectively in obstetric care.

“Because it is a point-of-care test that can be done at a patient’s bedside, it provides fast and detailed results within minutes, helping physicians make treatment decisions in real time,” said Carla Janzen, MD, PhD, first author of the publication.

Related Links:
Keck School of Medicine of USC


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Automated Urinalysis Solution
UN-9000
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new CRISPR-based technique enables simultaneous detection of multiple pathogens in a single test (photo courtesy of Shutterstock)

CRISPR-Based Test Identifies Multiple Respiratory Viruses Simultaneously

Respiratory virus co-circulation complicates differential diagnosis, as overlapping symptoms can obscure etiology. Multiplex testing typically depends on multiple enzymes or fluorophores and multistep... Read more

Pathology

view channel
Image: The researchers derived a gene-based signature and a blood test to help identify this high-risk subgroup (photo credit: Shutterstock)

New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease

Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage kidney disease, affecting 20%–40% of people with diabetes and more than 107 million individuals worldwide as of 2021.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.